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GATA factors orchestrate hematopoiesis via multistep transcriptional mechanisms, but the interrelation-
ships and importance of individual steps are poorly understood. Using complementation analysis with GATA-
1-null cells and mice containing a hypomorphic allele of the chromatin remodeler BRG1, we dissected the
pathway from GATA-1 binding to cofactor recruitment, chromatin loop formation, and transcriptional acti-
vation. Analysis of GATA-1-mediated activation of the -globin locus, in which GATA-1 assembles dispersed
complexes at the promoters and the distal locus control region (LCR), revealed molecular intermediates,
including GATA-1-independent and GATA-1-containing LCR subcomplexes, both defective in promoting loop
formation. An additional intermediate consisted of an apparently normal LCR complex and a promoter
complex with reduced levels of total RNA polymerase II (Pol II) and Pol II phosphorylated at serine 5 of the
carboxy-terminal domain. Reduced BRG1 activity solely compromised Pol II and serine 5-phosphorylated Pol
II occupancy at the promoter, phenocopying the LCR-deleted mouse. These studies defined a hierarchical order
of GATA-1-triggered events at a complex locus and establish a novel mechanism of long-range gene regulation.
Transcriptional networks involving coordinated actions of
numerous regulatory factors ensure high-fidelity cellular dif-
ferentiation and organogenesis. In the context of hemato-
poiesis, GATA factor networks are particularly important.
The hematopoietic GATA factors (GATA-1, GATA-2, and
GATA-3) have overlapping and unique expression patterns
and both shared and unique biological activities (11). GATA-2
(41, 81, 87) is crucial for the integrity/function of multipotent
hematopoietic precursors (72, 73) and regulates urogenital
(86), central nervous system (15, 51), and pituitary (12) devel-
opment. By contrast, GATA-1 (20, 74) promotes erythroid,
megakaryocyte, and mast cell development (48, 50, 58, 59,
67–69, 79, 82), and GATA-3 (28) regulates lymphopoiesis
(56, 70).
Analogous to many transcription factors, GATA-1 has a
dual zinc finger domain (54) and binds the histone acetyltrans-
ferase CBP/p300 (7). GATA-1 binds the coregulator Friend of
GATA-1 (FOG-1), which mediates activation and repression
(16, 75, 76). GATA-1 recruits FOG-1 (24) and associated
NuRD components (29, 37) to chromatin sites, where NuRD
mediates repression of certain target genes (29). GATA-1 also
binds PU.1 (52, 62, 83), Sp1 (46), and erythroid Krüppel-like
factor (EKLF) (46) and forms diverse multiprotein complexes
(29, 63). This complexity of protein-protein interactions might
reflect unique requirements for regulation of distinct loci. In-
deed, GATA-1 targets differ in their sensitivities to changes in
GATA-1 levels/activities (37), and factors occupying GATA-1
targets can differ (63).
Analysis of -like globin gene regulation led to the discovery
of GATA-1 (20, 74). The murine -like globin gene cluster
contains genes expressed during embryonic/fetal development
(Ey and H1) and in the adult (major and minor) (8, 39). A
far upstream locus control region (LCR) (21, 26) mediates
high-level transcription of the -like globin genes at all devel-
opmental stages (5, 19). Despite the presence of more than 200
GATA motifs (A/TGATAA/G) in the gene cluster, endoge-
nous and conditionally active GATA-1 proteins fused to the
estrogen receptor ligand binding domain (ER-GATA-1) oc-
cupy only a small subset of these motifs (32, 36). GATA-1
occupancy at additional chromosomal regions (23, 24, 33, 37,
45) further reveals an exquisite discrimination among GATA
motifs.
GATA-1-null (G1E) cells expressing ER-GATA-1 (G1E-
ER-GATA-1) have been an important system for dissecting
GATA-1 function (25), as ER-GATA-1 activation in G1E cells
recapitulates a normal window of erythropoiesis (80), ER-
GATA-1 and GATA-1 occupy similar chromatin sites (23, 32,
36, 45), and the ER-GATA-1 level/activity can be titrated by
varying the -estradiol or tamoxifen concentration (24, 32, 37,
45). A low ER-GATA-1 level/activity preferentially occupies
the LCR versus that in the adult major promoter, and ER-
GATA-1 occupies DNaseI hypersensitive sites (HSs) HS1,
HS2, HS3, and HS4 of the LCR prior to the promoter. The
elevation of diacetylated histone H3 (acH3) and binding of
additional factors also occur at the LCR prior to the promoter
(32). These results support a model involving GATA-1-depen-
dent LCR complex assembly and subsequent GATA-1-depen-
dent promoter complex assembly (32). Although this analysis
segregated certain steps, the interrelationship and importance
of individual steps are largely unknown. For example, CBP/
p300, the BRG1 component of the SWI/SNF chromatin re-
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modeling complex, EKLF, and FOG-1 occupy the LCR (32),
but it is unclear whether they are corecruited or independently
recruited and whether they collectively or independently reg-
ulate Pol II recruitment.
The orders of events of transcriptional activation at endog-
enous loci appear to be highly context dependent (1, 14, 27, 47,
66). At the Saccharomyces cerevisiae HO endonuclease pro-
moter, Swi5p promotes recruitment of SWI/SNF, followed by
the histone acetyltransferase GCN5 and then activator binding
(2, 14), whereas at the HeLa cell beta interferon promoter, an
enhanceosome recruits GCN5, followed by histone acetylation
at the promoter, CBP and Pol II recruitment, and then SWI/
SNF recruitment (2, 14). The differing sequences of reactions
might reflect context-dependent activation requirements. In
this regard, GATA-1 regulates transcription via FOG-1-depen-
dent activation (16), FOG-1-independent activation (16),
FOG-1-dependent repression (16), FOG-1-independent re-
pression (33), and FOG-1-independent activation coupled to
FOG-1-dependent repression (37).
Unlike the HO and beta interferon promoters discussed
above, regulation of the -globin locus and other complex
mammalian chromatin domains involves assembly of dispersed
complexes over broad chromosomal regions (8, 17). The LCR
HSs, which are all important for full transcriptional activation
(6), form a higher-order “active chromatin hub” (71). Many
questions regarding how dispersed complexes function at com-
plex loci and how their activities are dynamically regulated
during cellular differentiation remain unanswered. Herein, we
demonstrate that GATA-1-mediated -globin locus activation
can be resolved into discrete molecular steps that provide
fundamental insights into chromatin domain activation.
MATERIALS AND METHODS
Cell culture. G1E cells expressing ER-GATA-1 (32) or ER-GATA-1(V205G)
were cultured in Iscove’s modified Dulbecco’s medium (GIBCO/BRL) contain-
ing 2% penicillin-streptomycin (GIBCO/BRL), 2 units/ml erythropoietin, 120
nM monothioglycerol (Sigma), 0.6% conditioned medium from a Kit ligand-
producing CHO cell line, 15% fetal bovine serum (FBS; GIBCO/BRL), and 1
g/ml puromycin (Sigma).
Quantitative ChIP assay. Real-time-PCR-based quantitative chromatin im-
munoprecipitation (ChIP) analysis was conducted as described previously (31).
Before -estradiol treatment, cells were grown for at least 24 h in medium
containing 15% charcoal-stripped FBS to eliminate steroids. The cells were then
cultured in medium containing 7.5% FBS-7.5% charcoal-stripped FBS with or
without 1 M -estradiol (Steraloids Inc.) for 48 h at 25°C or 37°C. Single-cell
suspensions were isolated from fetal livers of E12.5 Brg1null/ENU1 embryos, which
contain a null allele and a mutated allele (E1083G mutation in the catalytic
ATPase domain) generated via ethylnitrosourea mutagenesis (9). The cells were
cross-linked identically to G1E-ER-GATA-1 cells, except 4  106 cells were used
per immunoprecipitation condition. DNA was analyzed by real-time PCR (ABI
Prism 7000; PE Applied Biosystems). Primers amplified 50- to 150-bp amplicons,
specific product was measured by SYBR green fluorescence, product was quan-
titated relative to a standard curve of input chromatin, and dissociation curves
showed that PCRs yielded single products.
Quantitative RT-PCR. Total RNA was purified with TRIzol (GIBCO/BRL)
from the same cultures as those used for ChIP. cDNA was prepared by annealing
RNA (1 g) with 250 ng of a 5:1 mixture of random and oligonucleotide
(deoxyribosylthymine) primers preheated at 68°C for 10 min, followed by incu-
bation with Moloney murine leukemia virus reverse transcriptase (RT; 50 units)
(GIBCO/BRL) combined with 10 mM dithiothreitol (DTT), RNasin (Promega),
and 0.5 mM deoxynucleoside triphosphates at 42°C for 1 h. Reaction mixtures
were diluted to a final volume of 130 l and heat inactivated at 98°C for 5 min.
The reaction mixtures (15 l) contained 2.0 l of cDNA, 7.5 l of SYBR green
master mix (Applied Biosystems), and the appropriate primers. Product accu-
mulation was monitored by SYBR green fluorescence. Control reactions lacking
RT yielded little to no signal. Relative expression levels were determined from a
standard curve of serial dilutions of cDNA samples and were normalized to
Gapdh expression levels.
Protein analysis. For Western analysis, total cell lysates were prepared by
boiling 1  106 cells for 10 min in sodium dodecyl sulfate (SDS) sample buffer
(25 mM Tris, pH 6.8, 2% -mercaptoethanol, 3% SDS, 0.05% bromophenol
blue, and 5% glycerol). Lysates were resolved on SDS-polyacrylamide gels, and
proteins were detected by Western blotting using ECL Plus (Amersham Phar-
macia). To detect endogenous FOG-1, lysates were prepared in radioimmuno-
precipitation assay buffer (phosphate-buffered saline [PBS] supplemented with 2
mM DTT, 0.2 mM phenylmethylsulfonyl fluoride, and 20 g/ml leupeptin and
containing 0.5% Triton X-100, 0.1% sodium deoxycholate, and 0.1% SDS).
Lysates were cleared by centrifugation at 13,000  g for 30 min at 4°C, divided
into two aliquots, and immunoprecipitated with preimmune serum or rabbit
anti-FOG-1 polyclonal antibody (24). Immune complexes were collected by
adsorption to protein A-Sepharose and washed five times at 4°C with lysis buffer.
Proteins were resolved by SDS-polyacrylamide gel electrophoresis on an 8%
acrylamide gel and analyzed by Western blotting using ECL Plus.
Restriction endonuclease accessibility assay. Untreated and -estradiol-
treated (48 h) G1E-ER-GATA-1 cells cultured at 25°C or 37°C were collected by
centrifugation at 240  g for 6 min at 4°C. The cells were washed with ice-cold
PBS, resuspended in 1.5 volumes of lysis buffer (10 mM Tris-HCl, 10 mM NaCl,
3 mM MgCl2, 0.2% Nonidet P-40, and 10 mM DTT, pH 7.5), and incubated for
10 min at 4°C. Nuclei were collected by centrifugation at 600  g for 2 min,
resuspended in wash buffer (10 mM Tris-HCl, 10 mM NaCl, 3 mM MgCl2, and
10 mM DTT, pH 7.5), and collected again by centrifugation. Nuclei were resus-
pended in 1 New England Biolabs restriction enzyme buffer no. 2 at 2  107
nuclei/0.2 ml. Restriction enzyme was added to aliquots, which were incubated
for 45 min at 37°C. Reactions were terminated with 10 mM Tris-HCl, 25 mM
EDTA, and 1% SDS, pH 7.5; proteinase K (0.4 mg/ml) was added; and samples
were incubated overnight at 37°C. DNA was purified, and equal amounts of
DNA (15 g) were digested with appropriate restriction enzymes. Samples were
resolved on a 1.1% agarose gel, and fragments were detected by Southern
blotting with high-specific-activity, randomly primed probes.
3C assay. Chromosome conformation capture (3C) analysis was conducted as
described previously (24, 77). The following primers were used to analyze liga-
tion products: HS2, ATGACTCAGCACTGCTGTGCTCAAGCC; major,
GGTGGAAGGGGGTATTATGAACATTCGG.
Immunofluorescence microscopy. Untreated and -estradiol-treated (48 h)
G1E-ER-GATA-1 cells cultured at 25°C or 37°C were attached to slides by
cytospin centrifugation at 1,000  g for 5 min at room temperature. The cells
were fixed with 3.7% paraformaldehyde in PBS for 30 min at room temperature,
permeabilized with 0.2% Triton X-100 for 15 min at room temperature, and
blocked with PBS-Tween 20 (PBST) containing 10% normal fish serum
(Aveslab) for 1 h at 37°C. The cells were then incubated with rabbit anti-estrogen
receptor AB16 antibody (Lab Vision Corporation) in PBST (1:250 dilution)
containing 1% normal fish serum at 4°C overnight. After being washed in PBST,
the cells were incubated with Alexa Fluor 488 goat anti-rabbit immunoglobulin
G (IgG) antibody (Molecular Probes, Inc.) in PBST (1:500 dilution) containing 1%
normal fish serum for 1 h at 37°C. Coverslips were mounted in VECTASHIELD
(mounting medium containing DAPI [4,6-diamidino-2-phenylindole]) (Vector
laboratories, Inc.). Samples were analyzed with a microscope (Axiovert 200 M;
Carl Zeiss MicroImaging, Inc.) equipped with an -plan-FLUAR 100 1.45-
numerical-aperture oil immersion objective. Fluorescence images were collected
with a digital camera (AxioCam HRm; Carl Zeiss MicroImaging, Inc.). The
images were deconvoluted with Axiovision 4.3 software (Carl Zeiss Micro-
Imaging, Inc.). Similar results were obtained with an anti-GATA-1 polyclonal
antibody (data not shown).
Antibodies. Rabbit anti-GATA-1 polyclonal antibody was described previously
(32). Rabbit anti-Pol II (N-20, sc-899), anti-CBP (A-22, sc-369), and anti-BRG1
(H-88, sc-10768) antibodies were from Santa Cruz Biotechnology. Mouse mono-
clonal IgM anti-RNA polymerase II H14 (MMS-134R), which recognizes the
phosphoserine 5 version of Pol II, was from Covance Research Products. Affini-
Pure (Jackson ImmunoResearch) rabbit anti-mouse IgM -chain-specific anti-
body was used as the secondary antibody for the Phospho-Ser-5 Pol II ChIP
analysis. Anti-diacetylated histone H3 (06-599) antibody was from Upstate Bio-
technology. Anti-murine FOG-1 antibody was raised in rabbits (24). Anti-EKLF
monoclonal 7B2 was from James Bieker (Mt. Sinai School of Medicine, NY).
Anti-p45/nuclear factor erythroid 2 (anti-p45/NF-E2) rabbit polyclonal antibody
was described previously (49).
PCR primers. Oligonucleotide sequences are shown in Table 1.
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RESULTS AND DISCUSSION
Temperature sensitivity of GATA-1-mediated -globin locus
activation. We reasoned that reducing the cell culture temper-
ature might slow the kinetics of the multiple steps involved in
GATA-1-mediated -globin locus (Fig. 1A) activation. Cultur-
ing G1E-ER-GATA-1 cells at 25°C almost completely ablated
ER-GATA-1-mediated major activation (Fig. 1B, left), while
the expression levels of the constitutive RPII215 and Gapdh
genes were unaffected (Fig. 1B, middle, right). Impaired
major activation was not associated with reduced ER-
GATA-1 levels (Fig. 1C), and -estradiol induced ER-
GATA-1 nuclear localization similarly at 25°C and 37°C (Fig.
1D). The smaller cell and nucleus size at 37°C reflects greater
differentiation at 37°C.
We tested whether impaired major activation at 25°C re-
sults from defective chromatin occupancy or postoccupancy
steps. Quantitative ChIP analysis was used to measure ER-
GATA-1 occupancy at the four HSs of the LCR, the Ey pro-
moter, and the major promoter 48 h after ER-GATA-1 acti-
vation (Fig. 1E). ER-GATA-1 occupied HS1, HS3, and HS4
similarly at 25°C and 37°C, whereas occupancy at HS2 was 51%
lower at 25°C than at 37°C (Fig. 1E). ER-GATA-1 occupancy
at the major promoter was 82% lower at 25°C than at 37°C
(Fig. 1E). No occupancy was detected at the Ey promoter (Fig.
1E), which is not expressed in G1E-ER-GATA-1 cells (data
not shown) at 25°C or 37°C, with or without activated ER-
GATA-1. In addition to normal ER-GATA-1 occupancy at
HS1, HS3, and HS4, ER-GATA-1 occupied regulatory ele-
ments of additional loci (Fog1 intron 1, the Gata2 kb 2.8
region, and Tac-2 intron 7) identically at 25°C and 37°C (Fig.
1F, left and middle). ER-GATA-1 occupancy at the Eklf pro-
moter, -globin HS-26, and Alas2 intron 8 was 2-fold lower at
TABLE 1. Oligonucleotide primers
Designation Forward and reverse sequences (5–3) Designation Forward and reverse sequences (5–3)
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25°C than at 37°C (Fig. 1F, right). These results indicate that
decreased ER-GATA-1 occupancy at the major promoter at
25°C does not reflect a general loss of ER-GATA-1 chromatin
binding activity, but rather, occupancy at the major promoter
is unusually sensitive to reduced temperature.
Titrating ER-GATA-1 levels/activity with increasing -es-
tradiol concentrations, and also analyzing the kinetics of
ER-GATA-1 chromatin occupancy, revealed ER-GATA-1 oc-
cupancy at the LCR prior to the major promoter (32). De-
fective major activation at 25°C might therefore result from a
further reduction in the kinetics of promoter occupancy. To
test this possibility, G1E-ER-GATA-1 cells were treated with
-estradiol for up to 72 h at 25°C, and ER-GATA-1 occupancy
was measured. Extending the -estradiol treatment time to
72 h did not significantly increase occupancy at promoter or
LCR sites (Fig. 2A), and major mRNA did not increase at
72 h compared to the level at 48 h (Fig. 2B), indicating that the
temperature-sensitive step(s) mediates establishment of the
active major promoter. As steps regulating establishment and
maintenance of an active locus might be shared, we tested
whether maintenance is temperature sensitive. G1E-ER-
GATA-1 cells were treated with -estradiol for 24 h at 37°C to
FIG. 1. Temperature sensitivity of GATA-1-mediated -globin locus activation. (A) Murine -globin locus organization. DNaseI HSs are
depicted as filled circles, and embryonic (Ey and H1) and adult (maj and min) globin genes are depicted as boxes. (B) Quantitative RT-PCR
analysis of major, RPII215, and Gapdh mRNA transcripts in G1E-ER-GATA-1 cells cultured at 25°C or 37°C for 48 h after -estradiol treatment
(means 	 standard errors for three independent experiments). major and RPII215 mRNA levels were normalized to Gapdh levels. (C) Western
blot analysis of ER-GATA-1 expression in untreated and -estradiol-treated (48 h) G1E-ER-GATA-1 cells. (D) Immunofluorescence staining of
ER-GATA-1 in G1E-ER-GATA-1 cells under the same conditions as those for panel B (100 magnification). Representative images from two
independent experiments are shown. (E) Quantitative ChIP analysis of ER-GATA-1 occupancy at HS4, HS3, HS2, HS1, the Ey promoter, and the
major promoter in untreated and -estradiol-treated (48 h) G1E-ER-GATA-1 cells under the same conditions as those for panel B (means 	
standard errors for four independent experiments). (F) ChIP analysis of ER-GATA-1 occupancy at Fog1 intron 1, Gata2 HS-2.8, Tac-2 intron 7,
the Eklf promoter, -globin HS-26, and Alas2 intron 8 under the same conditions as those for panel B (means 	 standard errors for three
independent experiments). The symbols are identical to those defined in panel E. PI, preimmune sera.
FIG. 2. Establishment, but not maintenance, of the active -globin locus is temperature sensitive. (A) Quantitative ChIP analysis of ER-
GATA-1 occupancy at the LCR, the Ey promoter, and the major promoter in G1E-ER-GATA-1 cells cultured at 25°C for up to 72 h after
-estradiol treatment. (B) Real-time RT-PCR analysis of major mRNA normalized to Gapdh mRNA levels in G1E-ER-GATA-1 cells under the
same conditions (mean values from two independent experiments). (C) A schematic representation of the experimental strategy is shown at the
top. Replicate G1E-ER-GATA-1 cultures were treated with -estradiol at 37°C for 24 h, at which point one culture was continued at 25°C for 24 h,
while the other culture was maintained at 37°C for 24 h. Results are shown for quantitative ChIP analysis of ER-GATA-1 occupancy at the LCR,
the Ey promoter, and the major promoter in untreated (37°C), -estradiol-treated (37°C for 24 h or 37°C for 48 h), and -estradiol-treated/
temperature-shifted (37°C 3 25°C) G1E-ER-GATA-1 cells (mean values from 2 independent experiments). PI, preimmune sera.
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confer maximal major activation and subsequently incubated
at 25°C for 24 h. If maintenance of the active state is temper-
ature dependent, the temperature transition should decrease
promoter-bound ER-GATA-1. However, once ER-GATA-1
occupied the promoter, occupancy was insensitive to a subse-
quent 25°C incubation (Fig. 2C), indicating that establishment,
but not maintenance, of the active locus is temperature sensi-
tive.
Dissecting steps in chromatin domain activation: LCR com-
plex assembly. The failure of ER-GATA-1 to strongly activate
major at 25°C, despite nearly normal LCR occupancy, repre-
sents a unique system that allows dissection of the interrela-
tionship of the multiple steps in activation. Since ER-GATA-1
occupancy at the LCR for up to 20 h is associated with mod-
estly increased acetylated histone H3 (acH3) at the LCR (32,
43), we compared acH3 levels in untreated and -estradiol-
treated G1E-ER-GATA-1 cells at 25°C and 37°C. The 2-fold
increase in acH3 at HS3 after 48 h of ER-GATA-1 activation
(Fig. 3A) is consistent with that described previously after 20 h
(32). ER-GATA-1 activation for 48 h did not affect acH3 at
HS2 and HS4, whereas small increases were observed previ-
ously at 20 h (32). Importantly, highly enriched acH3 levels at
HS2, HS3, and HS4, relative to values for acH3 at the Ey
promoter and the control antibody, were indistinguishable at
the two temperatures, indicating that loss of this transcription-
ally permissive epigenetic mark does not underlie strongly im-
paired -globin locus activation.
GATA-1 physically interacts with CBP and regulates CBP
occupancy at certain chromatin sites (7, 43). Activated ER-
GATA-1 increased CBP occupancy at HS2, HS3, and HS4 1.5-
to 3-fold at 37°C but not at 25°C (Fig. 3B).
GATA-1-mediated stimulation of erythropoiesis requires
binding of GATA-1 to FOG-1 (16). FOG-1 occupies all
GATA-1-bound chromatin sites tested (24, 37, 57) and facili-
tates GATA-1 chromatin occupancy at certain sites (42, 57).
We tested whether ER-GATA-1 and FOG-1 similarly colocal-
ize at the LCR at 25°C and 37°C. FOG-1 occupied HS2, HS3,
and HS4 only at 37°C (Fig. 3C). The 2-fold decrease in
ER-GATA-1 occupancy at HS2 (Fig. 1E) without FOG-1 oc-
cupancy is consistent with reports that FOG-1 facilitates ER-
GATA-1 occupancy at HS2 but not at other HSs (42, 57).
At least as much Pol II resides at the LCR HSs as is present
at the active major promoter (34–36, 78). GATA-1 modestly
increases, but is not essential for, Pol II occupancy at HS2 and
HS3 (36). Since ER-GATA-1 occupies the LCR at 25°C, we
tested whether ER-GATA-1 occupancy is sufficient to recruit
Pol II. Western blotting revealed that Pol II levels were indis-
tinguishable at 25°C and 37°C (data not shown). Active ER-
GATA-1 increased Pol II occupancy at HS2 and HS3 2-fold
at 37°C (Fig. 3D). ER-GATA-1 did not increase Pol II occu-
pancy at HS2 at 25°C; occupancy in untreated cells was equiv-
alent to that in cells containing activated ER-GATA-1. Pol II
occupancy at HS4 decreased 2-fold upon ER-GATA-1 acti-
vation at 37°C, whereas Pol II occupancy at HS4 was constant
at 25°C. Importantly, despite the differences in regulation of
Pol II occupancy at HS4 and HS2, LCR-bound Pol II persisted
at 25°C.
GATA-1 functions with additional hematopoietic transcrip-
tion factors, including p45/NF-E2 and EKLF, to regulate the
expression of the -like globin genes (10). Thus, the role of
these factors in GATA-1-mediated chromatin domain regula-
tion needs to be considered. Similar to the scenario described
above in which Pol II occupies the LCR of the inactive -glo-
bin locus at 25°C, Pol II occupies the LCR, but not the pro-
moter, in CB3 erythroleukemia cells (44) lacking p45/NF-E2
(3, 53), in which major transcription is silenced (34, 35).
Although p45/NF-E2 is not required for Pol II occupancy at
the LCR (34, 35), p45/NF-E2 induces Pol II recruitment to the
major promoter (34, 36) and transcriptional activation (40,
44). p45/NF-E2 physically and functionally interacts with CBP/
p300 (22, 30), and therefore, reduced LCR-associated CBP at
25°C might result from loss of p45/NF-E2 occupancy. Both
p45/NF-E2 levels (data not shown) and occupancy (Fig. 3E) at
HS2 were 2-fold lower at 25°C than at 37°C. Thus, normal
ER-GATA-1 and half-maximal p45/NF-E2 occupancy suggest
that loss of CBP occupancy is not explained by the absence of
these factors. The persistent Pol II occupancy and acH3 at the
LCR at 25°C indicate that these factors are insufficient for CBP
occupancy.
ER-GATA-1 activation increases EKLF expression and
chromatin occupancy (32). Activated ER-GATA-1 increased
EKLF occupancy at HS2 and HS3 at 37°C (Fig. 3F), consistent
with the report that ER-GATA-1 activation for up to 20 h
increased EKLF occupancy at these sites (32). No EKLF oc-
cupancy was detected at these sites or at HS4 at 25°C. EKLF
binds BRG1 (38, 84), but EKLF occupancy and BRG1 occu-
pancy at the murine -globin locus do not correlate precisely
(32). Similar to those of EKLF and CBP, BRG1 occupancy at
the LCR was considerably lower at 25°C than at 37°C (Fig.
3G). Western blotting revealed similar levels of both EKLF
and BRG1 at 25°C and 37°C (data not shown).
The persistent acH3, Pol II, and p45/NF-E2 occupancy at
HS2 at 25°C, indicative of an LCR subcomplex, suggests that
loss of chromatin accessibility does not underlie the incom-
plete LCR complex assembly. The terms “complexes” and
“subcomplexes” refer to groups of factors assembled at a com-
mon chromatin site, and there is no evidence that stable com-
plexes exist prior to chromatin occupancy. Analysis of HaeIII
site accessibility at HS2 (Fig. 3H) revealed similar degrees of
cleavage at 25°C and 37°C (60% of templates cleaved). Thus,
despite the incompletely assembled LCR at 25°C lacking
FOG-1, CBP, EKLF, and BRG1, chromatin accessibility per-
sists.
Dissecting steps in chromatin domain activation: promoter
complex assembly. Deletion of the LCR via homologous re-
combination strongly reduces major transcription (5, 19) but
does not prevent all factors from occupying the major pro-
moter. p45/NF-E2 (65), GATA-1 (77), and EKLF (85) occupy
the promoter of an LCR-deleted allele in splenic samples from
phenylhydrazine-treated mice. In addition, 50% of the Pol II
associated with the promoter of a wild-type allele occupies the
promoter of the mutant allele (65). These findings suggest that
LCR complex assembly is not required for the assembly of at
least certain components of the promoter complex in the con-
text of an LCR-deleted allele.
As noted above, LCR components appear to assemble prior to
the promoter complex in G1E (32) and CB3 (34) cells. In the
context of the wild-type locus, certain steps at the LCR might be
required for subsequent steps at the promoter, or LCR and pro-
moter complex assembly might represent parallel pathways. Since
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FIG. 3. An LCR subcomplex assembles at 25°C. (A to G) Quantitative ChIP analysis of acH3 (A), CBP (B), FOG-1 (C), Pol II (D), p45/NF-E2
(E), EKLF (F), and BRG1 (G) chromatin occupancy at HS4, HS3, HS2, and the Ey promoter in G1E-ER-GATA-1 cells cultured at 25°C or 37°C
for 48 h after -estradiol treatment (means 	 standard errors for three or four independent experiments). (H) Chromatin accessibility at HS2.
Nuclei from untreated and -estradiol-treated (48 h) G1E-ER-GATA-1 cells cultured at 25°C or 37°C were incubated with 0, 50, or 100 units of
HaeIII for 45 min at 37°C, and cleavage was measured by Southern blotting. The Southern blotting strategy is shown at the top. -globin genes,
HSs, and probes are depicted as boxes, circles, and black bars, respectively. RI, EcoRI; H, HaeIII. A representative Southern blot is shown (lower
left). Parental fragments and cleavage products are indicated by arrows. Results for PhosphorImager analysis are shown (lower right) (mean values
from two independent experiments). Open bars, 50 units; filled bars, 100 units. PI, preimmune sera.
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assembly of certain LCR components is impaired at 25°C, we
tested whether the promoter complex assembles under these con-
ditions. ER-GATA-1 induced acH3 (Fig. 4A, left), CBP (Fig. 4B,
left), Pol II (Fig. 4C, left), FOG-1 (Fig. 4D), p45/NF-E2 (Fig. 4E),
EKLF (Fig. 4F), and BRG1 (Fig. 4G) occupancy at the promoter
at 37°C but not at 25°C. Analysis of cells cultured at 25°C (at
which point the LCR subcomplex forms) and then for 12 h at
37°C revealed subcomplex maturation and promoter complex
assembly (data not shown). acH3 occupancy (Fig. 4A, right), CBP
occupancy (Fig. 4B, right), and Pol II occupancy (Fig. 4C, right)
at the active RPII215 promoter were similar at 25°C and 37°C and
undetectable at the inactive necdin promoter.
Though the incompletely assembled LCR was not associated
with reduced chromatin accessibility at HS2 (Fig. 3H), pro-
moter accessibility was low under conditions in which ER-
GATA-1-induced promoter complex assembly was blocked at
25°C (Fig. 4H). ER-GATA-1 increased major promoter ac-
cessibility only at 37°C (Fig. 4H), indicating that the Pol II-,
p45/NF-E2-, and ER-GATA-1-containing LCR subcomplex is
insufficient to induce any steps in promoter complex assembly.
-Globin locus activation is associated with a higher-order
chromatin transition that positions the LCR near the adult
-like globin genes (71). EKLF (18) and GATA-1 (77) pro-
mote loop formation. We used 3C analysis to test whether the
ER-GATA-1-containing LCR subcomplex induces looping.
Despite similar cleavage efficiencies at 25°C and 37°C (Fig. 5A
and B, left), HS2 proximity to the major promoter increased
5-fold upon ER-GATA-1 activation only at 37°C (Fig. 5B,
right; C; and D). Unlike the results shown in Fig. 4, in which
ER-GATA-1 increased HaeIII accessibility at the promoter,
the 3C BglII digest involved a prolonged incubation with high
BglII levels, which would not be expected to reveal differential
sensitivities.
FOG-1-dependent GATA-1 target genes are preferentially
temperature sensitive. Defective looping and reduced ER-
GATA-1 occupancy at HS2 are reminiscent of phenotypes
seen in G1E cells expressing V205 mutants of ER-GATA-1,
which are defective in FOG-1 binding (42, 77). Active ER-
GATA-1 induced FOG-1 at 37°C, with little to no induction at
25°C (Fig. 6A). The equivalent ER-GATA-1-mediated induc-
tions of FOG-1 mRNA at 25°C and 37°C (Fig. 6C) indicate
that the failure of ER-GATA-1 to elevate FOG-1 protein
levels at 25°C represents a posttranscriptional defect. Under
conditions in which ER-GATA-1 is activated at 25°C and
FOG-1 protein levels remain largely constant, FOG-1 chroma-
tin occupancy at diverse target genes (Fog1, Gata2, Tac-2, Eklf,
-globin, and Alas2) was almost undetectable (Fig. 6B).
Because steady-state FOG-1 levels in cells containing acti-
vated ER-GATA-1 were lower at 25°C than at 37°C, we rea-
soned that FOG-1-dependent GATA-1 target genes would be
preferentially temperature sensitive. However, temperature-
sensitive major activation might be multifactorial, and FOG-
1-independent GATA-1 targets might also be dysregulated.
FOG-1-independent GATA-1 targets were identified from
studies of V205 mutants of GATA-1 (16) and by ER-GATA-1
expression in FOG-1-null cells (33, 37).
Expression of GATA-1-activated and -repressed genes was
analyzed in G1E-ER-GATA-1 cells treated with -estradiol
for 48 h at 25°C or 37°C. ER-GATA-1 activation of major,
Slc4a1, Alas2, Csf2r2, -globin, Ahsp, and Hebp1 was strongly
repressed at 25°C, whereas Tac-2, Epb4.9, Fog1, and Eklf ac-
tivation levels at 25°C were almost as high as, if not higher
than, those at 37°C (Fig. 6C). ER-GATA-1 strongly repressed
Kit and Myb at 37°C, but no significant repression was apparent
at 25°C (Fig. 6C). By contrast, ER-GATA-1 repressed Cpa3
and Sialy8 13- and 8.6-fold, respectively, albeit at a lower level
than at 37°C. GATA-1 target genes were therefore relatively
temperature insensitive or exhibited various degrees of tem-
perature sensitivity.
As activation of the temperature-insensitive genes Eklf,
Fog1, Epb4.9, and Tac-2 (Fig. 6C) is FOG-1 independent (16,
37), we tested whether temperature-sensitive and -insensitive
genes are exclusively FOG-1 dependent and independent,
respectively. Gene expression was analyzed in -estradiol-
treated (24 h) G1E lines stably expressing ER-GATA-1 or
ER-GATA-1(V205G) at levels differing by no more than two-
fold (data not shown). ER-GATA-1(V205G) activated major,
Slc4a1, Alas2, Csf2r2, -globin, Ahsp, and Hebp1 considerably
less than ER-GATA-1 (Fig. 6C). By contrast, ER-GATA-
1(V205G) activated Tac-2, Epb4.9, Fog1, and Eklf at least as
much as ER-GATA-1 (Fig. 6C). FOG-1 suppresses the mag-
nitude of GATA-1-mediated Tac-2 activation (37). ER-
GATA-1(V205G) repressed Cpa3 and Sialy8 but not Kit and
Myb (Fig. 6C). The ratio of expression for cells containing
activated ER-GATA-1 at 25°C or 37°C (25°C/37°C) correlated
(r 
 0.947) with the ratio of expression for cells containing
activated ER-GATA-1(V205G) or ER-GATA-1 (V205G/WT)
at 37°C (Fig. 6D), suggesting that impaired FOG-1 synthesis
and/or function is a key component of temperature sensitivity
(Fig. 6E).
BRG1 ensures maximal Pol II occupancy at the major
promoter. The SWI/SNF chromatin remodeling complex facil-
itates EKLF-dependent -globin promoter activation in vitro
(4). Since BRG1 occupies the LCR without ER-GATA-1 ac-
tivity and ER-GATA-1 increases BRG1 recruitment at certain
-globin locus sites (32), we tested whether LCR and promoter
complex assembly require BRG1.
Fetal liver cells were isolated from E12.5 mouse embryos
FIG. 4. All steps of promoter complex assembly are temperature sensitive. (A to G) Quantitative ChIP analysis of acH3 (A), CBP (B), and Pol
II (C) chromatin occupancy at the major (left), necdin, and RPII215 (right) promoters and FOG-1 (D), p45/NF-E2 (E), EKLF (F), and BRG1
(G) chromatin occupancy at the major promoter in G1E-ER-GATA-1 cells cultured at 25°C or 37°C for 48 h after -estradiol treatment (means 	
standard errors for three or four independent experiments). (H) Chromatin accessibility at the major promoter. Nuclei from untreated and
-estradiol-treated (48 h) G1E-ER-GATA-1 cells cultured at 25°C or 37°C were incubated with 0, 50, or 100 units of HaeIII for 45 min at 37°C,
and cleavage was measured by Southern blotting. The Southern blotting strategy is shown at the top. -Globin genes, HSs, and probes are depicted
as boxes, circles, and black bars, respectively. RI, EcoRI; RV, EcoRV; H, HaeIII. A representative Southern blot is shown (lower left). Parental
fragments and cleavage products are indicated by arrows. Results for PhosphorImager analysis are shown (lower right) (mean values from two
independent experiments). Open bars, 50 units; filled bars, 100 units. PI, preimmune sera.
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containing a Brg1 hypomorphic allele (Fig. 7A) that have re-
duced major expression (9). The E1083G mutation within the
ATPase domain does not affect ATPase activity, SWI/SNF
complex assembly, or chromatin binding (9) (Fig. 7B). While
there was little to no difference in RPII215 and Ey expression
(Fig. 7C, middle and right), major expression was 91% lower
in mutant cells than in wild-type cells (Fig. 7C, left). GATA-1
(Fig. 7D), p45/NF-E2 (Fig. 7E), and Pol II (Fig. 7F) occupied
HS4, HS3, and HS2 in wild-type and mutant cells similarly.
This result is consistent with ER-GATA-1, p45/NF-E2, and Pol
II occupancy at the LCR, without BRG1 occupancy, at 25°C
(Fig. 1 and 3). GATA-1 and p45/NF-E2 occupied the major
promoter normally in the mutant cells (Fig. 7D and E). Pol II
occupancy at the major promoter, but not the RPII215 pro-
moter, was significantly lower (51%; P 
 0.026) in mutant cells
than in wild-type cells (Fig. 7F). Pol II occupancy at major
exon 3 was 58% lower (P 
 0.002) in mutant cells than in
wild-type cells (0.095 	 0.014 and 0.223 	 0.023, respectively)
(data not shown).
An LCR-deleted allele of the -globin locus is characterized
by 50% lower Pol II occupancy in the major promoter than
in the wild-type allele and a more severe decrease in serine
5-phosphorylated Pol II (65). Pol II phosphorylation at serine
5 is an essential step in the transition from a stalled to an
elongating polymerase (60). Given the similar magnitudes of
decreased Pol II occupancy at the major promoter in Brg1
mutant mice (Fig. 7F) and mice containing the LCR-deleted
allele (65), we tested whether the more severe defect in serine
5-phosphorylated Pol II was also a hallmark of the locus in
Brg1 mutant mice. Serine 5-phosphorylated Pol II at the
major promoter was 71% lower in Brg1 mutant mice than in
wild-type mice, whereas its levels were indistinguishable at
HS3 and the RPII215 promoter (Fig. 7G). Thus, two hallmarks
of the molecular phenotypes associated with the LCR deletion
and the BRG1 mutation are reduced Pol II, and there is a
more severe reduction in serine 5-phosphorylated Pol II at the
major promoter (Fig. 7H and I).
Mechanistic insights arising from analysis of trapped mo-
lecular intermediates. Although studies have analyzed the co-
ordinated recruitment of transcription factors and coregulators
to chromatin at complex mammalian loci (13, 55), little is
known about whether initial steps permit subsequent steps to
proceed or whether subsequent steps occur independently. We
used two systems (temperature sensitivity and Brg1 hypomor-
phic mice) to address the interrelationship and importance of
individual steps in chromatin domain activation.
Analysis of temperature sensitivity revealed novel molecular
intermediates in chromatin domain activation. One intermedi-
ate present prior to ER-GATA-1 activation was characterized
by normal acH3 and Pol II at the LCR, submaximal p45/NF-E2
at the LCR, and an absence of ER-GATA-1 and FOG-1. A
second intermediate present after ER-GATA-1 activation at
25°C consisted of LCR-associated acH3, Pol II, ER-GATA-1,
and submaximal p45/NF-E2 but lacked FOG-1. Loss of LCR-
associated BRG1, EKLF, FOG-1, and CBP at 25°C indicates
that these factors are not required to maintain acH3, p45/NF-
E2, and Pol II at the LCR. Since looping is blocked at 25°C
(Fig. 5), establishment of acH3, p45/NF-E2, and Pol II at the
LCR precedes looping, and their maintenance does not re-
quire looping.
FIG. 5. ER-GATA-1-containing LCR subcomplex is insufficient to
promote formation of a higher-order chromatin loop. (A) The diagram
depicts the 3C strategy. BglII fragments and primers are depicted as
shaded and white rectangles, respectively. (B) The graph depicts BglII
cleavage efficiencies at HS2 and the major promoter, determined by
real-time PCR (left). The graph depicts a 3C analysis of the relative
proximity of -globin HS2 and the major promoter in untreated and
-estradiol-treated (48 h) G1E-ER-GATA-1 cells cultured at 25°C or
37°C (means 	 standard errors for three independent experiments)
(right). (C) Summary of nucleoprotein parameters analyzed at 25°C and
37°C. Factor occupancy: , maximal occupancy; , submaximal occu-
pancy; , no occupancy. HaeIII site accessibility: , maximal accessibility;
, low accessibility. 3C analysis: , looping; , no looping. (D) Model of
ER-GATA-1-dependent chromatin domain activation at 25°C and 37°C.
(Upper) ER-GATA-1 occupancy at the LCR at 25°C initiates assembly of
an LCR subcomplex involving increased acH3, chromatin accessibility,
and p45/NF-E2 and Pol II occupancy at the LCR, whereas major pro-
moter complex assembly is completely blocked. (Lower) ER-GATA-1
occupancy at the LCR and the major promoter at 37°C initiates multiple
events, including increased acH3 accessibility; FOG-1, CBP, EKLF, p45/
NF-E2, Pol II, and BRG1 occupancy; and looping.
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A distinct molecular intermediate was revealed from the
analysis of Brg1 mutant mice. Despite severely impaired
major activation in Brg1 mutant mice, only Pol II and serine
5-phosphorylated Pol II occupancy at the promoter and open
reading frame was inhibited. One cannot unequivocally rule
out a BRG1 requirement for other steps, as residual BRG1
activity in the mutant mice might fulfill such a requirement.
Importantly, the data establish that BRG1 confers maximal Pol
II recruitment, perhaps resembling the SWI/SNF activity for
mediating late events in peroxisome proliferator-activated re-
ceptor 2 promoter activation during adipogenesis (64).
LCR complex assembly prior to promoter complex assembly
was a common theme that emerged from our studies. It is
therefore instructive to consider why deleting the LCR from
the mouse -globin locus does not abrogate all molecular
events at the major promoter; p45/NF-E2, GATA-1, Pol II,
and EKLF occupy the major promoter of an LCR-deleted
allele (65, 77, 85). Thus, contact between the LCR and the
FIG. 6. FOG-1 is limiting at 25°C, and perturbation of FOG-1 function underlies the temperature sensitivity. (A) Western blot analysis of
immunoprecipitated endogenous FOG-1 (arrow) in untreated and -estradiol-treated (48 h) G1E-ER-GATA-1 cells cultured at 25°C or 37°C. The
result is representative of five independent experiments. (B) ChIP analysis of FOG-1 occupancy at Fog1 intron 1, Gata2 HS-2.8, Tac-2 intron 7,
the Eklf promoter, -globin HS-26, and Alas2 intron 8 in G1E-ER-GATA-1 cells under the same conditions as those for panel A (means 	 standard
errors for three independent experiments). PI, preimmune sera. (C) Real-time RT-PCR quantitation of mRNA levels from GATA-1 target genes
in G1E-ER-GATA-1 cells cultured at 25°C or 37°C for 48 h after -estradiol treatment and wild-type ER-GATA-1 (average for two clones) and
three V205G clones following treatment with 1 M -estradiol for 24 h (means 	 standard errors for three independent experiments). The values
represent ER-GATA-1-mediated activation or repression relative to values for cells containing inactive ER-GATA-1. Values for FOG-1-
independent target genes are highlighted with a gray background, but certain target genes designated FOG-1 independent, e.g., Sialy8, are not fully
regulated by ER-GATA-1(V205G). (D) Linear regression analysis of changes (n-fold) plotted as 25°C/37°C and V205G/wild-type (WT) ratios. The
inset graph represents an expansion of the lower values. (E) Multiple modes of GATA-1 transcriptional regulation. The analysis described herein
shows that limiting FOG-1 levels at 25°C correlate with defective transcriptional regulation of certain but not all GATA-1 target genes.
FOG-1-dependent activated and repressed genes are not appropriately regulated at 25°C, whereas ER-GATA-1 retains the capacity to regulate
FOG-1-independent activated and repressed genes at 25°C.
VOL. 27, 2007 GATA FACTOR REGULATION OF CHROMATIN 4561
FIG. 7. BRG1 activity is required for maximal Pol II occupancy at the major promoter but not the LCR. (A) Bright-field photographs of
wild-type (left) and Brg1 mutant (right) E12.5 embryos and fetal livers. (B) Schematic representation of wild-type (WT) and BRG1 mutant
(MT)-containing SWI/SNF complexes. (C) Quantitative real-time RT-PCR analysis of major, Ey, and RPII215 mRNA transcripts in WT or BRG1
MT E12.5 fetal liver cells. major, Ey, and RPII215 mRNA levels were normalized to Gapdh levels. Each graph depicts the relative expression
levels of a given gene (Ey, major, or RPII215) in wild-type versus mutant samples. Thus, one cannot compare the absolute signals of Ey and
major. (D to G) Quantitative ChIP analysis of GATA-1 (D), p45/NF-E2 (E), Pol II (F), and serine 5-phosphorylated Pol II (G) occupancy at
-globin locus sites and the RPII215 promoter in WT or BRG1 MT E12.5 fetal liver cells (means 	 standard errors for three or four independent
experiments). (H) Features of the molecular intermediate revealed by analysis of the Brg1 hypomorphic allele. The table summarizes GATA-1,
p45/NF-E2, total Pol II, and serine 5-phosphorylated Pol II occupancy at the HSs and the promoter of the -globin locus in BRG1 MT (left) and
WT (right) E12.5 fetal liver cells. , maximal occupancy detected; , lower-level occupancy detected. (I) Summary of chromatin domain
assembly in G1E cells expressing activated ER-GATA-1 at 25°C and in the fetal livers of BRG1 mutant mice. Steps that occur and are blocked
are indicated by  and , respectively. ND, not determined. (J) Model of GATA-1-mediated major activation. An LCR subcomplex assembles
in a GATA-1-independent manner. GATA-1 induces both LCR and promoter complex assembly, but since the LCR deletion does not abrogate
promoter complex assembly (65), it is assumed that GATA-1-mediated LCR and promoter complex assemblies involve parallel pathways. Looping
is not depicted, since our analyses did not segregate looping from promoter complex assembly. Both BRG1 (Fig. 7F) and the LCR (65) are required
to achieve maximal Pol II at the promoter, and therefore, the LCR might utilize BRG1 to confer maximal Pol II recruitment. However, an
important BRG1 function through the promoter cannot be ruled out. Finally, the model depicts the reported LCR-enhanced occupancy of the
promoter by serine 5-phosphorylated Pol II (65). PI, preimmune sera.
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promoter via looping is not required for assembly of at least
these components at the promoter. As 50% and 70% of
promoter-bound Pol II and serine 5-phosphorylated Pol II,
respectively, are lost from the LCR-deleted allele (65), and
major transcription is strongly reduced (5, 19), both resem-
bling the locus in Brg1 mutant mice (Fig. 7), it is attractive to
propose that the LCR utilizes BRG1 to confer maximal Pol II
recruitment to the promoter (Fig. 7J). Defective BRG1 uti-
lization might therefore underlie the LCR deletion pheno-
type. Since the LCR deletion changes the subnuclear local-
ization of the -globin locus (61), it will be informative to
determine if BRG1 regulates the subnuclear localization of
the locus.
Since 50% of Pol II persists at the promoter of an LCR-
deleted allele (65) and in Brg1 mutant mice (Fig. 7F), and
major expression is severely reduced with the LCR-deleted
allele (5, 19) and in Brg1 mutant mice (Fig. 7C), the relation-
ship between Pol II occupancy and mRNA accumulation is
clearly not linear. Serine 5 phosphorylation of the Pol II car-
boxy-terminal domain was 70% lower in the LCR-deleted
allele than in the wild-type allele, and therefore, it was pro-
posed that serine 5 phosphorylation can be limiting (65) (Fig.
7J). The 71% decrease in serine 5-phosphorylated Pol II in
Brg1 mutant mice, which resembles the 90% decrease in
major mRNA, indicates that both the LCR and BRG1 func-
tion to ensure maximal serine 5-phosphorylated Pol II at the
promoter. Further dissecting how the molecular intermediates
described herein assemble and disassemble and the BRG1
activity for selectively maximizing Pol II at the promoter will
provide additional fundamental insights into the function of
regulatory complexes dispersed over a long distance on a chro-
mosome.
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